Foeniculum vulgareon bone and lipid profile
Phase 3
- Conditions
- menopause.Menopausal and female climacteric states
- Registration Number
- IRCT2016070428789N1
- Lead Sponsor
- Mashhad University of Medical Sciences, Vice chancellor for research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
postmenopausal status, which was defined as aged between 45-65 with no vaginal bleeding for 1 year no regular ingestion of phytoestrogen or soy-based products ; having a normal mammogram in the last year.The exclusion criteria were : use of any fluoride or bisphosphonates; diseases or medications affecting bone metabolism; Currently (or in the past 6 months) using estrogen or calcitonin; medication for lowering lipids or blood pressure diabetes mellitus; no regular physical exercise or allergy to
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method High density lipoprotein (HDL). Timepoint: before and 90 days after treatment. Method of measurement: biochemical test.;Osteoporosis. Timepoint: before intervention and 90 days after intervention. Method of measurement: the dual energy X-ray absorptiometry was utilized to measure bone mineral density (BMD).;Low density lipoprotein (LDL). Timepoint: beforer and after tratment. Method of measurement: biochemical test.;Total cholesterol. Timepoint: before and 90 days after treatment. Method of measurement: biochemical test.;Triglycerides. Timepoint: Before and after 90 days treatment. Method of measurement: biochemical test.
- Secondary Outcome Measures
Name Time Method